Ubenimex
Ubenimex
Ubenimex (pronounced: yoo-beh-nih-mex) is a medicinal compound used primarily in the treatment of chronic myelocytic leukemia and pulmonary arterial hypertension. It is also known by its trade name, Bestatin.
Etymology
The term "Ubenimex" is derived from the pharmaceutical company that first developed the drug, Ube Industries, and the suffix "-mex" which is commonly used in the naming of medicinal compounds.
Usage
Ubenimex is an enzyme inhibitor that works by blocking the action of certain enzymes in the body that can affect the growth and spread of cancer cells. It is typically administered orally in the form of a tablet.
Related Terms
- Leukemia: A type of cancer that affects the blood and bone marrow.
- Enzyme Inhibitor: A substance that reduces the activity of an enzyme.
- Chronic Myelocytic Leukemia: A type of cancer that starts in certain blood-forming cells of the bone marrow.
- Pulmonary Arterial Hypertension: A type of high blood pressure that affects the arteries in the lungs and the right side of the heart.
Side Effects
Like all medications, Ubenimex can cause side effects. Common side effects include nausea, vomiting, and diarrhea. More serious side effects can include anemia, neutropenia, and thrombocytopenia.
Precautions
Before starting Ubenimex treatment, patients should inform their healthcare provider about any other medications they are taking, as Ubenimex can interact with other drugs. It is also important to monitor blood counts regularly while taking this medication.
External links
- Medical encyclopedia article on Ubenimex
- Wikipedia's article - Ubenimex
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski